I agree that this site is using cookies. You can find further informations here.
X
Ciuleanu, Tudor Eliade
99  results:
Search for persons X
?
1

Next-generation sequencing as a valuable tool for mutationa..:

Berindan-Neagoe, Ioana ; Braicu, Cornelia ; Ciuleanu, Tudor Eliade...
Medicine and Pharmacy Reports.  , 2024
Link: https://doi.org/10.15386..
 
?
2

MicroRNAs expression profile in chemotherapy-induced cardio..:

Romitan, Mihai ; Zanoaga, Oana ; Budisan, Liviuta...
Biomolecules and Biomedicine.  , 2023
Link: https://doi.org/10.17305..
 
?
3

Exploring Therapeutic Avenues in Lung Cancer: The Epigeneti..:

Munteanu, Raluca ; Tomuleasa, Ciprian ; Iuga, Cristina-Adela..
Cancers.  15 (2023)  22 - p. 5394 , 2023
Link: https://doi.org/10.3390/..
 
?
4

Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovaria..:

Vidra, Radu ; Ciuleanu, Tudor Eliade ; Nemeș, Adina...
International Journal of Environmental Research and Public Health.  19 (2022)  7 - p. 4314 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Potential Biomarkers for the Efficacy of PD-1-PD-L Blockade..:

Grecea, Miruna ; Soritau, Olga ; Dulf, Daniel..
OncoTargets and Therapy.  14 (2021)  - p. 5275-5291 , 2021
Link: https://doi.org/10.2147/..
 
?
6

Namodenoson in Advanced Hepatocellular Carcinoma and Child–..:

Stemmer, Salomon M. ; Manojlovic, Nebojsa S. ; Marinca, Mihai Vasile...
Cancers.  13 (2021)  2 - p. 187 , 2021
Link: https://doi.org/10.3390/..
 
?
7

Erratum to: A phase II open-label randomized study to asses..:

Bodoky, György ; Timcheva, Constanta ; Spigel, David Robert...
Investigational New Drugs.  30 (2011)  3 - p. 1272-1273 , 2011
Link: https://doi.org/10.1007/..
 
?
8

A phase II open-label randomized study to assess the effica..:

Bodoky, György ; Timcheva, Constanta ; Spigel, David Robert...
Investigational New Drugs.  30 (2011)  3 - p. 1216-1223 , 2011
Link: https://doi.org/10.1007/..
 
?
9

P-593 Concurrent chemoradiotherapy with navelbine and cispl..:

Rusu, Petronela ; Ciuleanu, Tudor Eliade ; Cernea, Dana...
Lung Cancer.  41 (2003)  - p. S241 , 2003
Link: https://doi.org/10.1016/..
 
?
10

Sotorasib (960 mg or 240 mg) once daily in patients with pr..:

Hochmair, Maximilian J. ; Vermaelen, Karim ; Mountzios, Giannis...
European Journal of Cancer.  , 2024
Link: https://doi.org/10.1016/..
 
?
11

Four-year clinical update and treatment switching-adjusted ..:

Carbone, David P. ; Ciuleanu, Tudor-Eliade ; Schenker, Michael...
Journal for ImmunoTherapy of Cancer.  12 (2024)  2 - p. e008189 , 2024
Link: https://doi.org/10.1136/..
 
?
12

Use of Different Anti-PD-1 Checkpoint Combination Strategie..:

Preda, Alexandra-Cristina ; Ciuleanu, Tudor-Eliade ; Todor, Nicolae...
Cancers.  16 (2024)  11 - p. 2022 , 2024
Link: https://doi.org/10.3390/..
 
?
13

First-Line Nivolumab Plus Ipilimumab With Chemotherapy Vers..:

Paz-Ares, Luis G. ; Ciuleanu, Tudor-Eliade ; Cobo, Manuel...
Journal of Thoracic Oncology.  18 (2023)  2 - p. 204-222 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Systemic and Intracranial Outcomes With First-Line Nivoluma..:

Reck, Martin ; Ciuleanu, Tudor-Eliade ; Lee, Jong-Seok...
Journal of Thoracic Oncology.  18 (2023)  8 - p. 1055-1069 , 2023
Link: https://doi.org/10.1016/..
 
?
15

First-line nivolumab plus ipilimumab for metastatic non-sma..:

Ready, Neal E ; Audigier-Valette, Clarisse ; Goldman, Jonathan W...
Journal for ImmunoTherapy of Cancer.  11 (2023)  2 - p. e006127 , 2023
Link: https://doi.org/10.1136/..
 
1-15